Poland - Pharmaceutical products

Description

The subject of the contract is the supply of pharmaceutical products. The subject of the contract is specified in detail in Annexes 2A and 2B to the ToR.
Trastuzumabum emtansinum.The subject of the contract is described in detail in Appendix 2A to the ToR. Trastuzumumabum. The subject matter of the contract is described in detail in Appendix no. 2A to the ToR. Fulvestran.The subject matter of the contract is described in detail in Appendix no. 2A to the ToR. Pertuzumumabum.The subject matter of the contract is described in detail in Appendix no. 2A to the ToR. Calcii folinas.The subject matter of the contract is described in detail in Appendix no. 2A to ToR. Filgrastimum.The subject matter of the contract is described in detail in Annex No. 2A to the ToR. Atezolizumabum.The subject matter of the contract is described in detail in Annex No. 2A to ToR. Cabazitaxelum.the subject matter of the contract is described in detail in Annex 2A to the ToR. Dexamethasoni natrii phosphas.The subject matter of the contract is described in detail in Annex 2A to the ToR. Abemaciclibum.The subject matter of the contract is described in detail in Annex 2A to the ToR. Acidum ascorbicum, Ferri hydroxidum saccharum. The subject of the contract is described in detail in Annex 2B to the ToR. Desfluranum, Sevofluranum. The subject matter of the contract is described in detail in Annex 2B to the ToR. Bupivacainum hydrochloricum.The subject matter of the contract is described in detail in Annex 2B to the ToR. Barren gel. The subject matter of the contract is described in detail in Annex No. 2B to ToR. Obinutuzumabum.The subject matter of the contract is described in detail in Annex 2B to the ToR. Durvalumabum.The subject matter of the contract is described in detail in Annex 2B to ToR. Fentanylum.The subject matter of the contract is described in detail in Annex no. 2B to ToR. Ketaminum.The subject matter of the contract is described in detail in Annex no. 2B to ToR. Oxycodoni.The subject matter of the contract is described in detail in Annex no. 2B to ToR. The subject matter of the contract is described in detail in Annex No. 2B to ToR. The subject of the contract is described in detail in Annex 2B to the ToR. The subject matter of the contract is described in detail in Annex No. 2B to ToR. Morphini Sulfas/Morphini.The subject of the contract is described in detail in Annex 2B to the ToR. The subject of the contract is described in detail in Annex 2B to the ToR. Morphini sulfas/Morphini.The subject of the contract is described in detail in Annex 2B to the ToR. Human Insulin. The subject matter of the contract is described in detail in Annex 2B to ToR. Ketoprofenum, Paracetamolum, Rosuvastatinum, Thiamazolum, Propranololum. The subject matter of the contract is described in detail in Annex 2B to the ToR. The subject matter of the contract is described in detail in Annex No. 2B to the ToR. The subject matter of the contract is described in detail in Annex No. 2B to ToR. Hydrocortisonum.The subject matter of the contract is described in detail in Annex no. 2B to ToR. Acetylcysteinum.The subject matter of the contract is described in detail in Annex 2B to ToR. Ferrosi sulfas.The subject matter of the contract is described in detail in Annex 2B to ToR. Kalii canrenoas.The subject matter of the contract is described in detail in Annex 2B to the ToR. Lactulosum flakon.The subject of the contract is described in detail in Annex 2B to the ToR. Ornithini aspartas, Pancreatinum, Meglumini amidotrizoas + Natrii amidotrizoas, Prescription - Ung. Cholesterol, Heparinum natricum, Omeprazolum, Zinci oxidi unguentum. The subject of the contract is described in detail in Annex 2B to the ToR. The subject of the contract is described in detail in Annex 2B to the ToR. The subject matter of the contract has been described in detail in Appendix No. 2B to ToR. Betamethasoni dipropionas + Betamethasoni natrii phosphas, Thiethylperazinum, Estazolamum, Quetiapinum, Quetiapinum, Pregabalinum, Pregabalinum, Promazini hydrochloridim, Vinpocetinum, Opipramolum, Chlorpromazini hydrochloridim.The subject matter of the contract is described in detail in Annex 2B to the ToR.

Opportunity closing date

18 November 2020

Value of contract

to be confirmed